However, there was no association of ZBTB16 methylation with clinicopathological characteristics of patients, including age, tumor grade and size, lymph node metastasis, distant metastasis, ER, PR, HER2, or p53 status. Here, ZBTB16 is linked to metastatic malignant neoplasm in the lymph nodes.